Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetry
- DOI
- 10.1007/s00259-026-07948-6
- Published
- 2026-05-29
- Container
- European Journal of Nuclear Medicine and Molecular Imaging
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-026-07948-6,
title = {Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetry},
author = {Marnix Lam and David Kersting and William Harris and Eveline Boucher and Etienne Garin and Kirk Fowers and Riad Salem},
year = {2026},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
doi = {10.1007/s00259-026-07948-6},
url = {https://doi.org/10.1007/s00259-026-07948-6}
}RIS
TY - JOUR TI - Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetry AU - Marnix Lam AU - David Kersting AU - William Harris AU - Eveline Boucher AU - Etienne Garin AU - Kirk Fowers AU - Riad Salem PY - 2026 JO - European Journal of Nuclear Medicine and Molecular Imaging DO - 10.1007/s00259-026-07948-6 UR - https://doi.org/10.1007/s00259-026-07948-6 ER -
APA
Lam, M., Kersting, D., Harris, W., Boucher, E., Garin, E., Fowers, K., & Salem, R. (2026). Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetry. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07948-6
Source records
- crossref · retrieved 2026-09-26T03:48:11.804Z